Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
ACORDA THERAPEUTICS, INC.
*MAILING ADDRESS
420 Saw Mill River Road
*CITY
Ardsley
*STATE
(Required for U.S. applicants)
New York
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
60604
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis
and other diseases, disorders or conditions of the nervous system
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Joseph C. Guagliardo
ATTORNEY DOCKET NUMBER
15809073.006
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Dentons US LLP
STREET
P.O. Box 1302
CITY
Chicago
STATE
Illinois
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
60604
PHONE
215-981-4865
FAX
312-876-7934
EMAIL ADDRESS
trademarks.us@dentons.com
OTHER APPOINTED ATTORNEY
Benjamin P. Harbuck and all other Dentons US LLP attorneys
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97139656
Filing Date:11/23/2021
To the Commissioner for Trademarks:
MARK: AMKIA (Standard Characters, see mark)
The literal element of the mark consists of AMKIA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, ACORDA THERAPEUTICS, INC., a corporation of Delaware, having an address of
420 Saw Mill River Road
Ardsley, New York 60604
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other diseases,
disorders or conditions of the nervous system
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Joseph C. Guagliardo. Other appointed attorneys are Benjamin P. Harbuck and all other Dentons US LLP attorneys. Joseph C. Guagliardo of
Dentons US LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
P.O. Box 1302
Chicago, Illinois 60604
United States
215-981-4865(phone)
312-876-7934(fax)
trademarks.us@dentons.com
The docket/reference number is 15809073.006.
Joseph C. Guagliardo submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97139656
Payment Accounting Date: 11/23/2021
Serial Number: 97139656
Internet Transmission Date: Tue Nov 23 14:33:30 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202111231433308
17354-97139656-7814b32943b2fdffe7ce46bcf
3f6423e48653f25db23e1bb5b7781c76ae8a776-
CC-33290590-20211123142142561814